Cargando…
Therapeutic Potential of Tauroursodeoxycholic Acid for the Treatment of Osteoporosis
Tauroursodeoxycholic acid (TUDCA) is a US FDA-approved hydrophilic bile acid for the treatment of chronic cholestatic liver disease. In the present study, we investigate the effects of TUDCA on the proliferation and differentiation of osteoblasts and its therapeutic effect on a mice model of osteopo...
Autores principales: | Ahn, Tae-Keun, Kim, Kyoung-Tae, Joshi, Hari Prasad, Park, Kwang Hwan, Kyung, Jae Won, Choi, Un-Yong, Sohn, Seil, Sheen, Seung-Hun, Shin, Dong-Eun, Lee, Soo-Hong, Han, In-Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349164/ https://www.ncbi.nlm.nih.gov/pubmed/32560070 http://dx.doi.org/10.3390/ijms21124274 |
Ejemplares similares
-
Transplantation of tauroursodeoxycholic acid–inducing M2‐phenotype macrophages promotes an anti‐neuroinflammatory effect and functional recovery after spinal cord injury in rats
por: Han, Gong Ho, et al.
Publicado: (2021) -
3’-UTR Polymorphisms of Vitamin B-Related Genes Are Associated with Osteoporosis and Osteoporotic Vertebral Compression Fractures (OVCFs) in Postmenopausal Women
por: Ahn, Tae-Keun, et al.
Publicado: (2020) -
Safety and Tolerability of Stromal Vascular Fraction Combined with β-Tricalcium Phosphate in Posterior Lumbar Interbody Fusion: Phase I Clinical Trial
por: Kim, Kyoung-Tae, et al.
Publicado: (2020) -
Safety and efficacy of Wharton's jelly‐derived mesenchymal stem cells with teriparatide for osteoporotic vertebral fractures: A phase I/IIa study
por: Shim, JeongHyun, et al.
Publicado: (2020) -
An Injectable Hyaluronan–Methylcellulose (HAMC) Hydrogel Combined with Wharton’s Jelly-Derived Mesenchymal Stromal Cells (WJ-MSCs) Promotes Degenerative Disc Repair
por: Choi, Un Yong, et al.
Publicado: (2020)